Cara Therapeutics | CARA - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Acadia Pharmaceuticals USD 146.88M 1.69M 2026-09
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Cara Therapeutics USD 2.09M 96K 2026-03
Cassava Sciences USD 3.37M 521K 2026-06
Chugai Pharma JPY 32.37B 3.32B 2026-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.44M 5K 2026-06
CSL USD 1.23B 498M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 58.24M 1.24M 2026-09
J&J USD 6.25B 168M 2026-09
Neurocrine Biosciences USD 366.3M 16.8M 2026-09
Pacira USD 950.8M 858.99M 2026-09
Pfizer USD 3.28B 132M 2026-09
RedHill Biopharma USD 4.48M 1.52M 2024-03
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12